Kezar Life Sciences (KZR) Current Assets (2021 - 2025)
Historic Current Assets for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $94.5 million.
- Kezar Life Sciences' Current Assets fell 3956.93% to $94.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.5 million, marking a year-over-year decrease of 3956.93%. This contributed to the annual value of $137.5 million for FY2024, which is 3356.46% down from last year.
- Per Kezar Life Sciences' latest filing, its Current Assets stood at $94.5 million for Q3 2025, which was down 3956.93% from $104.7 million recorded in Q2 2025.
- Over the past 5 years, Kezar Life Sciences' Current Assets peaked at $311.3 million during Q2 2022, and registered a low of $94.5 million during Q3 2025.
- Moreover, its 5-year median value for Current Assets was $185.6 million (2024), whereas its average is $193.2 million.
- As far as peak fluctuations go, Kezar Life Sciences' Current Assets surged by 13961.51% in 2022, and later plummeted by 3956.93% in 2025.
- Quarter analysis of 5 years shows Kezar Life Sciences' Current Assets stood at $211.7 million in 2021, then skyrocketed by 34.99% to $285.7 million in 2022, then fell by 27.57% to $207.0 million in 2023, then crashed by 33.56% to $137.5 million in 2024, then crashed by 31.27% to $94.5 million in 2025.
- Its Current Assets was $94.5 million in Q3 2025, compared to $104.7 million in Q2 2025 and $120.3 million in Q1 2025.